Anti-tumor activity of patient-derived NK cells after cell-based immunotherapy – a case report

Table 5 Hsp70 protein and Hsp70 antibody levels in the serum of the patient within the last three treatment cycles, as determined by standard commercial ELISA technique

	Hsp70 protein serum levels (ng/ml)	Hsp70 antibody levels (μg/ml)
Treatment cycle*
Before L7	10.9 ± 0.4	6,049 ± 129
Before L8	13.2 ± 0.8	5,380 ± 145
Before L9	13.3 ± 0.7	3,191 ± 122
Healthy individuals
(n = 60) [40]	2.07 ± 2.74	280 ± 58
(n = 95) [41]	4.93	207 ± 55

*The data of the patient represent mean values of at least 4 independent experiments, the healthy individuals were determined with commercial ELISA kits.

ISSN: 1479-5876